Blended Resources for Integrated Diabetes Guidance and Empowerment
ConditionType 2 Diabetes Mellitus
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorPeking University
About this trial
The goal of this cluster randomized clinical trial is to learn if an AI-enabled blended care model (the BRIDGE program) works to treat type 2 diabetes in adults. It will also learn about the cost-effectiveness and implementation feasibility of this model in primary care settings. The main questions it aims to answer are:
Does the AI-driven intervention lower HbA1c levels (blood sugar) compared to standard care?
Does this model improve participants' quality of life, self-management behaviors, and digital literacy?
Researchers will compare the "Diet-Medicine Companion" (Shi Yi Ban Lv) mini-program combined with family doctor support to standard community care to see if the blended care model works to manage diabetes.
Participants will:
Use the "Diet-Medicine Companion" mini-program to upload diet photos daily and receive AI feedback for 6 months
Receive periodic guidance and phone reminders from case administrators (family doctors)
Complete questionnaires and blood tests (HbA1c) at baseline, 3 months, and 6 months
Eligibility criteria
Qualifiers
Aged 18 to 70 years (inclusive).
Glycosylated hemoglobin (HbA1c) level ≥ 6.5%.
Resided in the local area for at least 6 months.
Capable of using a smartphone to take photos and use the WeChat mini-program.
Disqualifiers
Diagnosed with Type 1 diabetes, gestational diabetes, or secondary diabetes.
Presence of severe diabetic complications.
Received radiotherapy or chemotherapy within the past 6 months.
Diagnosed with severe intellectual disabilities, Alzheimer's disease, or other serious psychiatric disorders.
Trial design
Treatments tested in this trial
- AI-driven Dietary Management and Human-in-the-loop Support
Treatment groups
1,200 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov